Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 29;121(25):2733-9.
doi: 10.1161/CIRCULATIONAHA.109.912170. Epub 2010 Jun 14.

Survival of kidney transplantation patients in the United States after cardiac valve replacement

Alok Sharma  1 , David T Gilbertson, Charles A Herzog
Affiliations

Survival of kidney transplantation patients in the United States after cardiac valve replacement

Alok Sharma et al. Circulation. .

Abstract

Background: Few published studies address the survival of kidney transplantation patients after valve surgery, and none address relative outcomes related to tissue versus nontissue prosthesis. This study aimed to assess survival of US kidney transplantation patients after cardiac valve replacement and to compare associations of valve selection.

Methods and results: Of 1 698 706 patients in the US Renal Data System database, we identified 1335 kidney transplantation patients hospitalized in 1991 to 2004 for cardiac valve replacement. Survival was estimated by the Kaplan-Meier method; independent predictors of death were examined in a comorbidity-adjusted (by Charlson and propensity score) Cox model. Of the cohort, 17% were 0 to 44 years of age, 50% were 45 to 64 years of age, 28% were 65 to 74 years of age, and 5% were > or =75 years of age; 78% were white; 63% were men; and 20% had kidney failure caused by diabetes mellitus. Of 369 patients (28%) who received tissue valves, 75% had aortic valve replacement, 20% had mitral valve replacement, and 5% had both. Use of tissue valves increased from 13% in 1991 to 1995 to 38% in 2000 to 2004. Age, diabetes mellitus, and combined aortic and mitral valve replacement were the strongest predictors of all-cause mortality. In-hospital mortality was 14.0% overall, 11.4% for tissue-valve patients, and 15.0% for nontissue-valve patients (P=0.09). Two-year survival estimates were 61.5% for tissue-valve and 59.5% for nontissue-valve patients (P=0.30). The adjusted hazard ratio of death for tissue- versus nontissue-valve patients was 0.83 (95% confidence interval, 0.70 to 0.99).

Conclusions: Renal transplantation patients requiring valve replacement have high mortality rates ( approximately 20%/y). These data suggest minimally reduced mortality risk for patients receiving tissue versus nontissue valves.

PubMed Disclaimer

Conflict of interest statement

Disclosure

The authors have no conflicts of interest with the subject matter of this manuscript.

Figures

Figure 1
Figure 1
Estimated unadjusted all-cause survival for patients who received tissue and nontissue valves.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. U.S. Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
    1. U.S. Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
    1. U.S. Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
    1. Organ Procurement and Transplantation Network. 2009. [Accessed March 8, 2010]. Available at: http://optn.transplant.hrsa.gov/latestData/viewDataReports.asp.
    1. Abbott KC, Hshieh P, Cruess D, Agadoa LY, Welch PG, Taylor AJ, Yuan CM. Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes. Clin Nephrol. 2003;59:79–87. - PubMed

Publication types

MeSH terms